As of Thursday close, Johnson & Johnson’s (NYSE:JNJ) stock was up $1.62, moving up 0.94 percent to $174.01. The average number of shares traded per day over the past five days has been 71,073,141 shares. 2 times new highs have been achieved over the past 5 days, with a $1.84 gain in that time frame. In the last twenty days, the average volume was 33,372,551, while in the previous 50 days, it was 17,674,139.
Since last month, JNJ stock rose 9.62%. Shares of the company fell to $157.33 on 07/19/23, the lowest level in the past month. A 52-week high of $181.04 was reached on 01/06/23 after having rallying from a 52-week low of $150.11. Since the beginning of this year, JNJ’s stock price has dropped by -1.49% or -$2.64, and marked a new high 3 times. However, the stock has declined by -3.88% since its 52-week high.
JNJ stock investors should be aware that Johnson & Johnson (JNJ) stock had its last reported insider trading activity 23 days ago on Jul 26. Hait William, the of the company, disposed of 14,698 shares for $172.00 on Jul 26. It resulted in a $2,528,056 divestment by the insider. Fasolo Peter sold 20,000 shares at an average price of $170.32 on Jul 25. The insider now owns 102,696 shares following the transaction. On Jun 12, EVP, Chief TO and Risk Officer Wengel Kathryn E sold 12,465 shares at $160.00 apiece. The transaction was valued at $1,994,400.
Valuation Metrics
Right now, Johnson & Johnson (JNJ) has a P/E ratio of about 35.26. The stock’s beta is 0.53. Besides these, the trailing price-to-sales (P/S) ratio of 4.58, the price-to-book (PB) ratio of 6.02, and the price-to-cash flow ratio of 30.79 may also be considered.
The latest dividend of $1.19 per share was paid out, remained unchanged from last year’s $1.19.
Financial Health
In the three months ended June 29, Johnson & Johnson’s quick ratio stood at 0.90, while its current ratio was 1.10, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.45, and the total debt-to-equity ratio was 0.61. On the profitability front, the trailing twelve-month gross margin is 67.20% percent. In the year ended June 29, EBITDA margin amounted to 33.42%, whereas operating margins totaled 16.40%. Based on annual data, JNJ earned $63.85 billion in gross profit and brought in $94.94 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 15.40%. Return on equity (ROE) for the past 12 months was 17.60%.
In Johnson & Johnson’s quarter-end financial report for June 29, it reported total debt of $33.9 billion against cash and short-term investments of $7.32 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. JNJ’s revenue rose 5.91% to $24.75 billion during the quarter, while net income inched up to $25.53 billion. While analysts expected Johnson & Johnson to report $2.62 quarterly earnings, the actual figure was $2.8 per share, beating the consensus estimate by 6.90%. During the quarter, the company generated $9.41 billion in EBITDA. The liabilities of Johnson & Johnson were 115.28 billion at the end of its most recent quarter ended June 29, and its total debt was $45.6 billion. The value of shareholders’ equity is $2.6 billion.
Technical Picture
This quick technical analysis looks at Johnson & Johnson’s (JNJ) price momentum. With a historical volatility rate of 15.19%, the RSI 9-day stood at 63.11% on 17 August.
With respect to its five-day moving average, the current Johnson & Johnson price is up by +1.07% percent or $1.84. At present, JNJ shares trade +3.34% above its 20-day simple moving average and +13.99% percent above its 100-day simple moving average. However, the stock is currently trading approximately +10.01% above its SMA50 and -0.49% below its SMA200.
Stochastic coefficient K was 71.17% and Stochastic coefficient D was 71.53%, while ATR was 3.06. Given the Stochastic reading of 80.22% for the 14-day period, the RSI (14) reading has been calculated as 62.56%. As of today, the MACD Oscillator reading stands at -0.01, while the 14-day reading stands at 1.39.
Analyst Ratings
Johnson & Johnson (JNJ) has been rated Overweight by analysts. According to 0 brokerage firms, JNJ is a sell, and 14 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate Johnson & Johnson stock as buy, with 6 recommending it as overweight.
With a median target price of $182.00, the current consensus forecast for the stock is $167.00 – $215.00. Based on these forecasts, analysts predict Johnson & Johnson (JNJ) will achieve an average price target of $183.67.
